{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:55Z","timestamp":1791378355527,"version":"4.3.2"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12328-026-02388-z","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:45:42Z","timestamp":1783403142000},"page":"1222-1227","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3419-8444","authenticated-orcid":false,"given":"Sho","family":"Tazuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Onoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuaki","family":"Sumiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"2388_CR1","first-page":"7","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2388_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ctrv.2017.08.007","volume":"60","author":"M Chiaravalli","year":"2017","unstructured":"Chiaravalli M, Reni M, O\u2019Reilly EM. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies. Cancer Treat Rev. 2017;60:32\u201343.","journal-title":"Cancer Treat Rev"},{"key":"2388_CR3","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1158\/1078-0432.CCR-16-3169","volume":"24","author":"BA Krantz","year":"2018","unstructured":"Krantz BA, O\u2019Reilly EM. Biomarker-based therapy in pancreatic ductal adenocarcinoma: an emerging reality? Clin Cancer Res. 2018;24:2241\u201350.","journal-title":"Clin Cancer Res"},{"key":"2388_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2019.03.003","volume":"75","author":"RR Singh","year":"2019","unstructured":"Singh RR, Goldberg J, Varghese AM, et al. Genomic profiling in pancreatic ductal adenocarcinoma and a pathway towards therapy individualization: A scoping review. Cancer Treat Rev. 2019;75:27\u201338.","journal-title":"Cancer Treat Rev"},{"key":"2388_CR5","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nrc3612","volume":"13","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Hsu PP, Awad MM, et al. Tyrosine kinase gene rearrangements in epithelial malignancies. Nat Rev Cancer. 2013;13:772\u201387.","journal-title":"Nat Rev Cancer"},{"key":"2388_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/diagnostics12030668","volume":"12","author":"B Koopman","year":"2022","unstructured":"Koopman B, Kuijpers C, Groen HJM, et al. Detection of NTRK fusions and TRK expression and performance of pan-TRK immunohistochemistry in routine diagnostics: results from a nationwide community-based cohort. Diagnostics (Basel). 2022;12:668.","journal-title":"Diagnostics (Basel)"},{"key":"2388_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","volume":"33","author":"JP Solomon","year":"2020","unstructured":"Solomon JP, Linkov I, Rosado A, et al. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol. 2020;33:38\u201346.","journal-title":"Mod Pathol"},{"issue":"Suppl8","key":"2388_CR8","doi-asserted-by":"publisher","first-page":"viii36","DOI":"10.1093\/annonc\/mdz385","volume":"30","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, Hechtman JF. Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion. Ann Oncol. 2019;30(Suppl8):viii36\u201340.","journal-title":"Ann Oncol"},{"key":"2388_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.18.00039","volume":"2","author":"MJ Pishvaian","year":"2018","unstructured":"Pishvaian MJ, Garrido-Laguna I, Liu SV, et al. Entrectinib in TRK and ROS1 fusion-positive metastatic pancreatic cancer. JCO Precis Oncol. 2018;2:1\u20137.","journal-title":"JCO Precis Oncol"},{"key":"2388_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","volume":"11","author":"T Jiang","year":"2021","unstructured":"Jiang T, Wang G, Liu Y, et al. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. Acta Pharm Sin B. 2021;11:355\u201372.","journal-title":"Acta Pharm Sin B"},{"key":"2388_CR11","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.3390\/cancers16193395","volume":"16","author":"MA Gouda","year":"2024","unstructured":"Gouda MA, Thein KZ, Hong DS. Tissue-agnostic targeting of neurotrophic tyrosine receptor kinase fusions: current approvals and future directions. Cancers (Basel). 2024;16:3395.","journal-title":"Cancers (Basel)"},{"key":"2388_CR12","doi-asserted-by":"publisher","first-page":"115618","DOI":"10.1016\/j.ejmech.2023.115618","volume":"258","author":"HB El-Nassan","year":"2023","unstructured":"El-Nassan HB, Al-Qadhi MA. Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: A mini review. Eur J Med Chem. 2023;258:115618.","journal-title":"Eur J Med Chem"},{"key":"2388_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11523-018-0590-1","volume":"13","author":"S Kummar","year":"2018","unstructured":"Kummar S, Lassen UN. TRK inhibition: a new tumor-agnostic treatment strategy. Target Oncol. 2018;13:545\u201356.","journal-title":"Target Oncol"},{"key":"2388_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","volume":"7","author":"A Drilon","year":"2017","unstructured":"Drilon A, Nagasubramanian R, Blake JF, et al. A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion-positive solid tumors. Cancer Discov. 2017;7:963\u201372.","journal-title":"Cancer Discov"},{"issue":"8","key":"2388_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","volume":"378","author":"A Drilon","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378(8):731\u20139.","journal-title":"N Engl J Med"},{"key":"2388_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele RC, Drilon A, Paz-Ares L, et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet Oncol. 2020;21:271\u201382.","journal-title":"Lancet Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02388-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:43:09Z","timestamp":1791376989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02388-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2388"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02388-z","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}